![James Ward-Lilley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Ward-Lilley
Président chez
Adherium (NZ) Ltd.
Profil
James Ward-Lilley is currently the Independent Non-Executive Chairman at Adherium (NZ) Ltd. and a Director at Vectura Group Investments Ltd., Aerogen Pharma Ltd., Aerogen Ltd., and Galway Group LLC.
Previously, he served as the Chief Executive Officer & Executive Director at Vectura Group Ltd. from 2015 to 2019, and as the Chief Executive Officer & Director at Vectura GmbH.
He was also a Director at Vectura Ltd. and Vectura Group Services Ltd. Additionally, he worked as the Head-Investor Relations at AstraZeneca PLC from 2011 to 2012.
He briefly served as the Independent Non-Executive Chairman at Adherium Ltd. from 2020 to 2022.
Postes actifs de James Ward-Lilley
| Sociétés | Poste | Début |
|---|---|---|
Vectura Group Investments Ltd.
 Vectura Group Investments Ltd. Medical SpecialtiesHealth Technology Manufactures products for airways diseases | Directeur/Membre du Conseil | 31/07/2018 |
Galway Group LLC
 Galway Group LLC Oil & Gas ProductionEnergy Minerals Galway Group is a prominent energy advisory firm that was established in 1995 by former senior executives from the energy industry. The company offers a wide range of services in the energy sector, including strategic assessments, project development and execution, commercial negotiations, financing, capital raises, energy marketing and trading, and risk management. Galway Group operates through its four primary affiliates: Galway Energy Advisors, Galway Capital, LLC, and Galway Broker/Dealer, which provide commercial advisory services, energy consulting, and financial services. The company is based in Houston, TX. | Corporate Officer/Principal | - |
Aerogen Ltd.
 Aerogen Ltd. Medical SpecialtiesHealth Technology Develops and manufactures aerosol products | Corporate Officer/Principal | - |
Aerogen Pharma Ltd.
 Aerogen Pharma Ltd. Aerogen Pharma Ltd. specializes in acute care aerosol drug delivery technology, focusing on vibrating mesh nebuliser devices that produce consistently sized aerosol droplets for effective lung deposition across various respiratory therapies, including invasive and non-invasive ventilation, high-flow therapy, and self-ventilating patients. The company is based in GA. Key products include the Aerogen Solo, Aerogen Ultra, Aerogen Pro controller, and the continuous nebulisation tube set, all designed to deliver precise medication and support closed-circuit delivery to reduce infection risk. The Irish company ’ s technology is compatible with multiple ventilator brands and supports physician-prescribed inhalation medications. Aerogen Pharma also provides educational resources and collaborates on research initiatives related to respiratory care. | Directeur/Membre du Conseil | - |
Adherium (NZ) Ltd.
 Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Develops digital health technologies that address sub-optimal medication use in chronic disease | Président | 14/04/2020 |
Anciens postes connus de James Ward-Lilley
| Sociétés | Poste | Fin |
|---|---|---|
| ADHERIUM LIMITED | Président | - |
| VECTURA GROUP | Directeur Général | 30/06/2019 |
Vectura Group Services Ltd.
 Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Directeur/Membre du Conseil | 30/06/2019 |
| ASTRAZENECA PLC | Investor Relations Contact | 01/01/2012 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
32
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
Aerogen Ltd.
Aerogen Ltd. Medical SpecialtiesHealth Technology Develops and manufactures aerosol products | Health Technology |
Vectura GmbH
 Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
Adherium (NZ) Ltd.
Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Develops digital health technologies that address sub-optimal medication use in chronic disease | Technology Services |
Adherium Ltd.
 Adherium Ltd. Medical SpecialtiesHealth Technology Develops and manufactures solutions for the pharmaceutical sector | Health Technology |
Vectura Ltd.
 Vectura Ltd. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Vectura Group Services Ltd.
Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Vectura Group Investments Ltd.
Vectura Group Investments Ltd. Medical SpecialtiesHealth Technology Manufactures products for airways diseases | Health Technology |
Galway Group LLC
Galway Group LLC Oil & Gas ProductionEnergy Minerals Galway Group is a prominent energy advisory firm that was established in 1995 by former senior executives from the energy industry. The company offers a wide range of services in the energy sector, including strategic assessments, project development and execution, commercial negotiations, financing, capital raises, energy marketing and trading, and risk management. Galway Group operates through its four primary affiliates: Galway Energy Advisors, Galway Capital, LLC, and Galway Broker/Dealer, which provide commercial advisory services, energy consulting, and financial services. The company is based in Houston, TX. | Energy Minerals |
Aerogen Pharma Ltd.
Aerogen Pharma Ltd. Aerogen Pharma Ltd. specializes in acute care aerosol drug delivery technology, focusing on vibrating mesh nebuliser devices that produce consistently sized aerosol droplets for effective lung deposition across various respiratory therapies, including invasive and non-invasive ventilation, high-flow therapy, and self-ventilating patients. The company is based in GA. Key products include the Aerogen Solo, Aerogen Ultra, Aerogen Pro controller, and the continuous nebulisation tube set, all designed to deliver precise medication and support closed-circuit delivery to reduce infection risk. The Irish company ’ s technology is compatible with multiple ventilator brands and supports physician-prescribed inhalation medications. Aerogen Pharma also provides educational resources and collaborates on research initiatives related to respiratory care. |
